Core Insights - Hims & Hers Health, Inc. (HIMS) is transforming health and wellness through a consumer-first digital platform, providing treatment for chronic and sensitive conditions, and has conducted over 30 million telehealth consultations in the U.S. and U.K. [1][7] Company Overview - HIMS offers accessible care for mental health, dermatology, sexual wellness, and weight management via its mobile app [7] - The company is expanding its services to include lab testing, compounded medications, and personalized digital wellness solutions [7] Industry Trends - According to McKinsey's 2025 Future of Wellness Trends survey, wellness is increasingly important to consumers, especially Gen Z and millennials, leading to a demand for accessible, science-backed, and personalized solutions [3] - Hims & Hers is well-positioned in the evolving wellness industry with a scalable, tech-enabled model that emphasizes individualized care and proactive health management [3] Competitive Landscape - LifeMD, Inc. (LFMD) focuses on direct-to-patient telehealth services for lifestyle and chronic health conditions, expanding its offerings in accessible digital healthcare [4] - Medifast, Inc. (MED) emphasizes lifestyle-based weight management through its OPTAVIA program, supporting over 25,000 active coaches and impacting over 3 million lives [5] Financial Performance - HIMS shares have increased by 90.6% year-to-date, significantly outperforming the industry growth of 9.9% [6] - The Zacks Consensus Estimate predicts a 174.1% increase in HIMS' earnings per share from 2024 to 2025 [8] Valuation Metrics - HIMS has a forward 12-month price-to-sales (P/S) ratio of 4.1X, which is lower than the industry average of 5.8X but higher than its three-year median of 2.3X [10]

Core Viewpoint - Tilray Brands, Inc. announced the approval of a reverse stock split at a ratio of 1-to-10 to 1-to-20, but has paused its implementation to evaluate timing and stock price [1][2]. Financial Structure - In the fiscal quarter ended February 28, 2025, Tilray reduced its total debt by approximately $76 million, resulting in a net debt to trailing twelve-months Adjusted EBITDA of less than 1.0x [3]. - As of the last fiscal quarter, Tilray's cash and marketable securities balance was approximately $250 million, providing financial strength and flexibility for strategic opportunities and acquisitions [3]. Strategic Objectives of Reverse Stock Split - The reverse stock split aims to ensure compliance with Nasdaq listing requirements, align the number of shares with similar companies, attract institutional shareholders, and potentially save up to $1 million annually in costs associated with stockholder meetings [7].

Group 1 - Tilray Brands, Inc. will participate in the TD Cowen 9th Annual Future of the Consumer Conference on June 3, 2025, in New York, with a fireside chat scheduled for 11:00 a.m. ET [1] - The company is recognized as a global leader in the lifestyle and consumer packaged goods sector, focusing on cannabis, beverage, wellness, and entertainment industries [3] - Tilray operates in multiple regions including Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands in more than 20 countries [3]

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis- ...